179 related articles for article (PubMed ID: 20167107)
1. Whole brain radiotherapy with a conformational external beam radiation boost for lung cancer patients with 1-3 brain metastasis: a multi institutional study.
Casanova N; Mazouni Z; Bieri S; Combescure C; Pica A; Weber DC
Radiat Oncol; 2010 Feb; 5():13. PubMed ID: 20167107
[TBL] [Abstract][Full Text] [Related]
2. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
[TBL] [Abstract][Full Text] [Related]
3. Systemic treatment after whole-brain radiotherapy may improve survival in RPA class II/III breast cancer patients with brain metastasis.
Zhang Q; Chen J; Yu X; Ma J; Cai G; Yang Z; Cao L; Chen X; Guo X; Chen J
J Neurooncol; 2013 Sep; 114(2):181-9. PubMed ID: 23743596
[TBL] [Abstract][Full Text] [Related]
4. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of X-ray stereotactic radiotherapy on brain metastases and prognostic analysis.
Wei W; Deng ML; Wu SX; Zeng ZF; Li FY; Wang HY; Bao Y; Gao YH; Chen LX
Chin J Cancer; 2010 Feb; 29(2):202-6. PubMed ID: 20109352
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors affecting survival after whole brain radiotherapy in patients with brain metastasized lung cancer.
Tsakonas G; Hellman F; Gubanski M; Friesland S; Tendler S; Lewensohn R; Ekman S; de Petris L
Acta Oncol; 2018 Feb; 57(2):231-238. PubMed ID: 28984492
[TBL] [Abstract][Full Text] [Related]
7. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
[TBL] [Abstract][Full Text] [Related]
8. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
[TBL] [Abstract][Full Text] [Related]
10. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
[TBL] [Abstract][Full Text] [Related]
12. Boost Irradiation Integrated to Whole Brain Radiotherapy in the Management of Brain Metastases.
Dobi Á; Fodor E; Maráz A; Együd Z; Cserháti A; Tiszlavicz L; Reisz Z; Barzó P; Varga Z; Hideghéty K
Pathol Oncol Res; 2020 Jan; 26(1):149-157. PubMed ID: 29344836
[TBL] [Abstract][Full Text] [Related]
13. Additional radiation boost to whole brain radiation therapy may improve the survival of patients with brain metastases in small cell lung cancer.
Sun H; Xu L; Wang Y; Zhao J; Xu K; Qi J; Yuan Z; Zhao L; Wang P
Radiat Oncol; 2018 Dec; 13(1):250. PubMed ID: 30563554
[TBL] [Abstract][Full Text] [Related]
14. Whole-brain radiotherapy plus sequential or simultaneous integrated boost for the treatment of a limited number of brain metastases in non-small cell lung cancer: A single-institution study.
Qing D; Zhao B; Zhou YC; Zhu HL; Ma DY
Cancer Med; 2020 Jan; 9(1):238-246. PubMed ID: 31749325
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
16. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
17. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
[TBL] [Abstract][Full Text] [Related]
18. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.
Chidel MA; Suh JH; Reddy CA; Chao ST; Lundbeck MF; Barnett GH
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):993-9. PubMed ID: 10863070
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Survival of Patients with Brain Metastases According to Prognostic Indexes and Treatment Strategies.
Saginc H; Baltalarli PB; Sagtas E; Coskun ME
Turk Neurosurg; 2020; 30(6):822-831. PubMed ID: 32091122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
